Zobrazeno 1 - 10
of 22
pro vyhledávání: '"CA-125 antigen/blood"'
Autor:
Hasan Yucel, Osman Beton, Ali Zorlu, Didem Oguz, Hakki Kaya, Mehmet Yilmaz, Hakan Güneş, Recep Kurt
Publikováno v:
Texas Heart Institute Journal. 44:22-28
WOS: 000394509600007
PubMed ID: 28265209
Length of stay is the primary driver of heart-failure hospitalization costs. Because cancer antigen 125 has been associated with poor morbidity and mortality rates in heart failure, we investigated t
PubMed ID: 28265209
Length of stay is the primary driver of heart-failure hospitalization costs. Because cancer antigen 125 has been associated with poor morbidity and mortality rates in heart failure, we investigated t
Autor:
Amine Bititi, Charles Chapron, Isabelle Streuli, Louis Marcellin, Magate M'Baye, Isabelle Melonio, Bruno Borghese, Marie-Christine Lafay Pillet, Pietro Santulli
Publikováno v:
Journal of Minimally Invasive Gynecology, Vol. 22, No 2 (2015) pp. 275-284
Study Objective To determine whether cancer antigen-125 (CA-125) levels are increased in women with endometriosis, especially in those with endometriomas (OMAs), deep infiltrating lesions (DIE), and superficial endometriosis (SUP) compared with contr
Autor:
Pierre Loubeyre, Michele Copercini, Seema Patel, Jean-Bernard Dubuisson, Patrick Petignat, Patrick Dällenbach
Publikováno v:
Journal of Clinical Ultrasound, Vol. 40, No 7 (2012) pp. 424-32
The main role of imaging is to provide a description of the appearance, size, and location of adnexal lesions and associated abnormalities. In some circumstances, the aggressive potential of an adnexal lesion may be suggested on the basis of the imag
Autor:
M. Pipino, M. De Santis, Cristani A, Paolo Ventura, D. Arioli, E. Boldrini, E. Amateis, M.L. Zeneroli, Elisa Romagnoli
Publikováno v:
Internal and Emergency Medicine. 2:88-94
In the last 35 years tumour markers (TM) have gained currency in clinical practice. However, in the light of indications by international guidelines, their use is often unjustified. Our aim was to quantify the use of some of the most common TM, asses
Autor:
Hakan Özhan, Harun Evrengul, Havane Asuman Kaftan, Mehmet Tosun, Serkan Ordu, Yusuf Izzettin Alihanoglu, Aybars Ozsoy, Bekir Serhat Yildiz
WOS: 000364706900007 PubMed: 25733317 Background: Heart rate (HR) reduction is associated with improved outcomes in patients with heart failure (HF) and biomarkers can be a valuable diagnostic tool in HF management. The primary aim of our study was t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8fa34955d8d93ff45a6daa31a83c8bb
https://hdl.handle.net/11499/10475
https://hdl.handle.net/11499/10475
Publikováno v:
Cleveland Clinic Journal of Medicine, Vol. 81, No 6 (2014) pp. 361-366
Endometriosis--the presence of endometrial tissue outside the uterine cavity--is first suspected on the basis of its signs and symptoms. The diagnosis is confirmed by imaging and surgery. Imaging, particularly transvaginal ultrasonography and magneti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ce5b118b73925cb2667034e4177a410
http://hdl.handle.net/11392/1983412
http://hdl.handle.net/11392/1983412
Publikováno v:
Kierkegaard, O, Mogensen, O, Mogensen, B & Jakobsen, A 1995, ' Predictive and prognostic values of cancer-associated serum antigen (CASA) and cancer antigen 125 (CA 125) levels prior to second-look laparotomy for ovarian cancer ', Gynecologic Oncology, vol. 59, no. 2, pp. 251-4 . https://doi.org/10.1006/gyno.1995.0017
CA 125 and cancer-associated serum antigen (CASA) were measured prior to second-look laparotomy (SLL) to investigate their predictive and prognostic values in 93 patients treated for epithelial ovarian cancer FIGO stage II, III, or IV. Residual tumor
Publikováno v:
Scopus-Elsevier
Kandis, Hayati/0000-0001-9151-6050 WOS: 000300117800007 PubMed: 22412224 Carbohydrate antigen-125 (CA-125) is emerging as a prognostic biomarker of risk in heart failure. In a prospective study, we compared the prognostic values of CA-125 and amino-t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::b71c77af536792a7ac4244ba9cc7337a
https://hdl.handle.net/20.500.12684/3001
https://hdl.handle.net/20.500.12684/3001
Publikováno v:
Expert review of molecular diagnostics. 11(5)
Ovarian cancer is the most deadly gynecological cancer. Despite biomedical research advances, medical progress over recent years in early detection, effective treatment and cure rates has been slow...
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.